OncoSil Medical Limited (ONCOSIL FPO [OSL]) aksje
OSL.AX
Stengt$0.4550-0.0300 (-6.19%)
Laster graf...
ONCOSIL FPO [OSL]
Market Cap
$14,054,449
Åpning0.4850
Høy0.4850
Lav0.4300
Volum164.95k
P/EN/A
Markedsverdi14.05M
52-ukers høy2.0900
52-ukers lav0.3700
Gj.sn. volum89.26k
UtbytteN/A
Beta1.18
EPS-0.9400
Om OncoSil Medical Limited (ONCOSIL FPO [OSL]) aksje
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Selskapsinformasjon
Børs: ASX (ASX)
Sektor: Sundhed
Industri: Medicinsk udstyr
Adresse:
7 Eden Park Drive
2113 Macquarie Park, Australia
2113 Macquarie Park, Australia
Telefon: + 61 2 8935 9629
Nettside: https://www.oncosil.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål